<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02807441</url>
  </required_header>
  <id_info>
    <org_study_id>UHCMC-Ortho</org_study_id>
    <nct_id>NCT02807441</nct_id>
  </id_info>
  <brief_title>Perioperative Bleeding and Aspirin Use in Spine Surgery</brief_title>
  <acronym>ASA</acronym>
  <official_title>Association Between Perioperative Bleeding and Aspirin Use in Spine Surgery: A Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospitals Cleveland Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospitals Cleveland Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators would like to further the current understanding of aspirin and its effects&#xD;
      on perioperative bleeding by conducting a randomized controlled trial of spinal surgery&#xD;
      patients receiving varying doses of aspirin or no aspirin perioperatively. The investigators&#xD;
      hypothesize that there will be no significant difference in perioperative blood loss between&#xD;
      the different groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Selected patients will be given either no aspirin, low-dose aspirin (81 mg), or high-dose&#xD;
      aspirin (325 mg) in the perioperative period. These dosages are based on the Pharmacist's&#xD;
      letter/Prescriber's letter which provides aspirin dosing recommendations for varying&#xD;
      cardiovascular indications. Allocation of dosing will be based on computerized randomization&#xD;
      in order to achieve approximately 100 patients in each group. Patient records will then be&#xD;
      assessed for demographic characteristics, comorbidities, symptoms, functional outcome scores&#xD;
      (Sf-12), operative time, intraoperative estimated blood loss, postoperative blood loss in&#xD;
      drainage tubes (when applicable), cumulative blood loss, transfusion of blood products,&#xD;
      hemoglobin level, preoperative International Normalized Ratio (INR), preoperative platelet&#xD;
      count, hospital length of stay, and morbidity and mortality including development of NSTEMI,&#xD;
      atrial fibrillation, surgical site infection, pulmonary embolism, and hospital 30-day&#xD;
      readmission rates.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Withdrawn</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemorrhage: Amount of blood loss</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Amount of blood loss from the operation will be recorded</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hemorrhage: Amount of blood loss</measure>
    <time_frame>48 hours Postoperative</time_frame>
    <description>Blood loss from drainage tube when applicable</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood Transfusion: Amount of blood products transfused</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Amount of blood products transfused when applicable</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Hemorrhage</condition>
  <condition>Thrombosis</condition>
  <arm_group>
    <arm_group_label>No aspirin</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients will not be given any Acetylsalicylic acid in the perioperative period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low-dose aspirin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be given low-dose Acetylsalicylic acid (81 mg) in the perioperative period.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>High-dose aspirin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will be given high-dose Acetylsalicylic acid (325 mg) in the perioperative period.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Acetylsalicylic acid</intervention_name>
    <description>Patients will receive different doses of aspirin perioperatively to assess bleeding association.</description>
    <arm_group_label>High-dose aspirin</arm_group_label>
    <arm_group_label>Low-dose aspirin</arm_group_label>
    <other_name>aspirin</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients over 18 years old, who are not taking aspirin at the time of operation as&#xD;
             part of a current cardiovascular treatment plan, who will undergo spinal surgery from&#xD;
             2016-2019 in the practice of Dr. Eubanks.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any patient under the age of 18 and/or is already taking anticoagulant therapy for an&#xD;
             established cardiovascular disease at the time of surgery as part of a cardiovascular&#xD;
             therapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jason Eubanks, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Cleveland Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospitals Case Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hall R, Mazer CD. Antiplatelet drugs: a review of their pharmacology and management in the perioperative period. Anesth Analg. 2011 Feb;112(2):292-318. doi: 10.1213/ANE.0b013e318203f38d. Epub 2011 Jan 6. Review.</citation>
    <PMID>21212258</PMID>
  </reference>
  <reference>
    <citation>Cuellar JM, Petrizzo A, Vaswani R, Goldstein JA, Bendo JA. Does aspirin administration increase perioperative morbidity in patients with cardiac stents undergoing spinal surgery? Spine (Phila Pa 1976). 2015 May 1;40(9):629-35. doi: 10.1097/BRS.0000000000000695.</citation>
    <PMID>26030214</PMID>
  </reference>
  <reference>
    <citation>Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively?: clinical impact of aspirin withdrawal syndrome. Ann Surg. 2012 May;255(5):811-9. doi: 10.1097/SLA.0b013e318250504e. Review.</citation>
    <PMID>22470078</PMID>
  </reference>
  <reference>
    <citation>Soleman J, Baumgarten P, Perrig WN, Fandino J, Fathi AR. Non-instrumented extradural lumbar spine surgery under low-dose acetylsalicylic acid: a comparative risk analysis study. Eur Spine J. 2016 Mar;25(3):732-9. doi: 10.1007/s00586-015-3864-7. Epub 2015 Mar 11.</citation>
    <PMID>25757534</PMID>
  </reference>
  <reference>
    <citation>Gerstein NS, Carey MC, Cigarroa JE, Schulman PM. Perioperative aspirin management after POISE-2: some answers, but questions remain. Anesth Analg. 2015 Mar;120(3):570-575. doi: 10.1213/ANE.0000000000000589. Review.</citation>
    <PMID>25695574</PMID>
  </reference>
  <reference>
    <citation>Manchikanti L, Abdi S, Atluri S, Benyamin RM, Boswell MV, Buenaventura RM, Bryce DA, Burks PA, Caraway DL, Calodney AK, Cash KA, Christo PJ, Cohen SP, Colson J, Conn A, Cordner H, Coubarous S, Datta S, Deer TR, Diwan S, Falco FJ, Fellows B, Geffert S, Grider JS, Gupta S, Hameed H, Hameed M, Hansen H, Helm S 2nd, Janata JW, Justiz R, Kaye AD, Lee M, Manchikanti KN, McManus CD, Onyewu O, Parr AT, Patel VB, Racz GB, Sehgal N, Sharma ML, Simopoulos TT, Singh V, Smith HS, Snook LT, Swicegood JR, Vallejo R, Ward SP, Wargo BW, Zhu J, Hirsch JA. An update of comprehensive evidence-based guidelines for interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician. 2013 Apr;16(2 Suppl):S49-283.</citation>
    <PMID>23615883</PMID>
  </reference>
  <reference>
    <citation>Park HJ, Kwon KY, Woo JH. Comparison of blood loss according to use of aspirin in lumbar fusion patients. Eur Spine J. 2014 Aug;23(8):1777-82. doi: 10.1007/s00586-014-3294-y. Epub 2014 Apr 17.</citation>
    <PMID>24740280</PMID>
  </reference>
  <reference>
    <citation>Kang SB, Cho KJ, Moon KH, Jung JH, Jung SJ. Does low-dose aspirin increase blood loss after spinal fusion surgery? Spine J. 2011 Apr;11(4):303-7. doi: 10.1016/j.spinee.2011.02.006.</citation>
    <PMID>21474081</PMID>
  </reference>
  <reference>
    <citation>Wong SS, Irwin MG. Peri-operative cardiac protection for non-cardiac surgery. Anaesthesia. 2016 Jan;71 Suppl 1:29-39. doi: 10.1111/anae.13305. Review.</citation>
    <PMID>26620144</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>June 14, 2016</study_first_submitted>
  <study_first_submitted_qc>June 20, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2016</study_first_posted>
  <last_update_submitted>October 3, 2021</last_update_submitted>
  <last_update_submitted_qc>October 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospitals Cleveland Medical Center</investigator_affiliation>
    <investigator_full_name>Heather Fuhrman</investigator_full_name>
    <investigator_title>medical student</investigator_title>
  </responsible_party>
  <keyword>Bleeding</keyword>
  <keyword>Aspirin</keyword>
  <keyword>Spine</keyword>
  <keyword>Surgery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thrombosis</mesh_term>
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aspirin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Data will be collected on a computer database containing unique identifiers, without names, social security numbers, medical record numbers, or other information that could be used to identify individuals. University Hospitals Research Electronic Data Capture will be used as a means of secure data storage. At no time will this data spreadsheet be printed or otherwise distributed, and no Protected Health Information will be transferred to investigators at other sites of this multi-center study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

